TC
NVCR icon

TwinBeech Capital’s NovoCure NVCR Stock Holding History

TwinBeech Capital’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,330
Closed -$146K – 749
2025
Q4 		$146K Buy
+11,330
New +$145K 0.01% 549
2024
Q4 		– Sell
-198,395
Closed -$3.1M – 835
2024
Q3 		$3.1M Buy
198,395
+73,267
+59% +$1.33M 0.06% 345
2024
Q2 		$2.14M Sell
125,128
-3,834
-3% -$67.4K 0.04% 328
2024
Q1 		$2.02M Sell
128,962
-48,439
-27% -$712K 0.04% 339
2023
Q4 		$2.65M Sell
177,401
-254,512
-59% -$3.41M 0.04% 361
2023
Q3 		$6.98M Buy
431,913
+146,737
+51% +$4.23M 0.13% 208
2023
Q2 		$11.8M Buy
285,176
+201,975
+243% +$12.5M 0.23% 131
2023
Q1 		$5M Buy
+83,201
New +$6.65M 0.1% 243
2022
Q3 		– Sell
-3,014
Closed -$209K – 752
2022
Q2 		$209K Sell
3,014
-7,937
-72% -$598K 0.01% 470
2022
Q1 		$907K Sell
10,951
-41,196
-79% -$3.03M 0.04% 333
2021
Q4 		$3.92M Buy
+52,147
New +$5.23M 0.22% 127
2020
Q2 		– Sell
-23,266
Closed -$1.57M – 462
2020
Q1 		$1.57M Buy
23,266
+18,565
+395% +$1.47M 0.63% 48
2019
Q4 		$396K Buy
+4,701
New +$379K 0.11% 254

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

TwinBeech Capital's NVCR Position: Q1 2026 in Review

TwinBeech Capital sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 11,330 shares — an estimated $146K sold.

TwinBeech Capital first reported a position in NVCR in Q4 2019 and held it in 13 quarters. The position peaked at $11.8M in Q2 2023. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • TwinBeech Capital reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • TwinBeech Capital sold 11,330 NovoCure shares in Q1 2026, an estimated $146K.
  • TwinBeech Capital first reported a position in NovoCure in Q4 2019 and held it in 13 quarters.
  • TwinBeech Capital's NovoCure position peaked at $11.8M in Q2 2023.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.